Closure Devices Market to Grow at 7.2% CAGR Through 2030 | Femoral Access Segment Dominates with Traditional Preference and Complex Procedure Compatibility | DataM Intelligence

Leander, Texas and Tokyo, Japan - Nov 27, 2025
According to DataM Intelligence, the global closure devices market is estimated to reach a high CAGR of 7.2% during the forecast period (2023-2030). This significant growth is propelled by increasing prevalence of cardiovascular diseases, rising minimally invasive surgical procedures, growing geriatric population, technological advancements in closure technologies, and expanding ambulatory surgery center adoption for vascular interventions.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/closure-devices-market?jd

Browse in-depth TOC on "Closure Devices Market"
60 - Tables
50 - Figures
180 - Pages

Recent Developments (November 2025)
✅ Abbott Laboratories (US) launched next-generation active vascular closure devices with enhanced safety features, specifically designed for complex femoral access procedures in cardiac catheterization labs.
✅ Cardinal Health, Inc. (US) expanded their passive vascular closure device portfolio, introducing advanced collagen-based technologies for improved hemostasis and reduced complication rates.
✅ Medtronic plc (Ireland) developed innovative external hemostatic devices with digital pressure monitoring, providing precise compression control for radial access procedures in ambulatory settings.
✅ Terumo Corporation (Japan) introduced specialized closure systems for hybrid operating rooms, featuring rapid deployment capabilities for both femoral and radial access sites.
✅ Boston Scientific Corporation (US) launched comprehensive closure solutions for specialty clinics, integrating vascular access management with patient recovery tracking.

Buy Now and Enjoy a 30% Year-End Discount: https://www.datamintelligence.com/buy-now-page?report=closure-devices-market

Competitive Landscape
The market features strong competition between global medical device companies, specialized vascular access providers, and surgical technology innovators.

1. Abbott Laboratories maintained market leadership with 28% global market share, expanding their active closure device portfolio and reporting 26% revenue growth in 2024-2025 through hospital partnerships.
2. Cardinal Health, Inc. captured 24% market share in passive closure technologies, securing contracts with ambulatory surgical centers and achieving 28% growth through product innovation.
3. Medtronic plc dominated the radial access segment with 22% market share, reporting 25% growth through advanced hemostasis solutions.
4. Terumo Corporation led hybrid procedure applications with 18% market share, achieving 23% growth through specialized closure systems.
5. Boston Scientific Corporation expanded their clinic solutions with 16% market share, focusing on outpatient care with 21% revenue growth.

Speak to Our Analyst and Get Customization in the Report: https://www.datamintelligence.com/customize/closure-devices-market?jd

Segmentation Analysis
By Product Type
• Active Vascular Closure Devices dominates the market with 45% revenue share in 2024, projected to grow at 7.8% CAGR, valued for immediate hemostasis achievement, reduced time to ambulation, improved patient comfort, and widespread adoption in complex interventional procedures requiring secure vascular access site management.
• Passive Vascular Closure Devices shows strong growth with 35% revenue share in 2024, expected to grow at 7.1% CAGR, preferred for cost-effectiveness, ease of use, and reliable performance in routine vascular access cases.
• External Haemostatic Devices demonstrates significant expansion with 20% revenue share in 2024, growing at 6.8% CAGR, valued for radial access procedures and specific patient populations.

By Access
• Femoral Access dominated the closure devices market with 62% revenue share in 2024, growing at 7.4% CAGR, driven by traditional procedural preferences, larger device compatibility, complex intervention requirements, established physician experience, and comprehensive closure solution availability for various femoral access scenarios across cardiac, vascular, and neurointerventional procedures.
• Radial Access shows accelerated growth with 38% revenue share in 2024, expected to grow at 8.9% CAGR, preferred for reduced bleeding complications, faster patient recovery, increased patient satisfaction, and growing adoption in coronary interventions and diagnostic procedures.

By End-User
• Hospitals leads the market with 55% revenue share in 2024, projected to grow at 7.5% CAGR, driven by high procedure volumes, complex case management, 24/7 emergency capabilities, comprehensive vascular services, and advanced interventional cardiology and radiology departments performing diverse closure-dependent procedures.
• Ambulatory Surgical Centers shows robust growth with 30% revenue share in 2024, expanding at 8.2% CAGR, valued for cost efficiency, specialized care focus, and growing preference for outpatient vascular interventions.
• Specialty Clinics demonstrates significant expansion with 15% revenue share in 2024 through focused vascular care services.

Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription?jd

Regional Analysis:
North America holds the largest market share with 46% revenue share in 2024, driven by advanced healthcare infrastructure, high procedural volumes, favorable reimbursement policies, strong physician training programs, and early adoption of innovative closure technologies across the United States and Canada.

Asia-Pacific emerges as the fastest-growing region, projected to expand at 9.5% CAGR through 2030, fueled by improving healthcare access, rising cardiovascular disease prevalence, growing medical tourism, expanding interventional capabilities, and increasing healthcare investments across China, India, Japan, and Southeast Asian countries.

Market Trends & Drivers
The Closure Devices Market is experiencing robust growth driven by minimally invasive procedure expansion, vascular access innovation, patient outcome focus, and healthcare efficiency demands. Key trends include the development of dual-access closure systems, growth of radial artery procedures, advancement in bioabsorbable technologies, expansion of outpatient closure solutions, and increasing focus on same-day discharge protocols. The procedural evolution, technological advancement, and healthcare economics are significantly contributing to market expansion.

Related Reports:
1. Interventional Cardiology and Peripheral Vascular Devices Market - https://www.datamintelligence.com/research-report/interventional-cardiology-and-peripheral-vascular-devices-market?jd
2. Surgical Staples Market - https://www.datamintelligence.com/research-report/surgical-staplers-market?jd
3. Surgical Sutures Market - https://www.datamintelligence.com/research-report/surgical-sutures-market?jd

Contact Us:
Sai Kiran
DataM Intelligence 4market Research LLP
Phone: +1 877-441-4866
Email: Sai.k@datamintelligence.com

About DataM Intelligence
DataM Intelligence is a renowned provider of market research, delivering deep insights through pricing analysis, market share breakdowns, and competitive intelligence. The company specialises in strategic reports that guide businesses in high-growth sectors such as nutraceuticals and AI-driven health innovations.
To find out more, visit https://www.datamintelligence.com/ or follow us on Twitter, LinkedIn and Facebook.

This release was published on openPR.